LOC643837 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.685600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.201000E-01
Normal-vs-Stage2
7.725000E-01
Normal-vs-Stage3
9.656800E-01
Normal-vs-Stage4
1.562980E-01
Stage1-vs-Stage2
4.571400E-01
Stage1-vs-Stage3
4.482800E-01
Stage1-vs-Stage4
7.676600E-01
Stage2-vs-Stage3
7.021800E-01
Stage2-vs-Stage4
4.490300E-02
Stage3-vs-Stage4
1.207250E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.895000E-01
Normal-vs-AfricanAmerican
5.733400E-01
Normal-vs-Asian
5.964800E-01
Caucasian-vs-AfricanAmerican
8.060000E-01
Caucasian-vs-Asian
8.511200E-01
AfricanAmerican-vs-Asian
9.235400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.221400E-01
Normal-vs-Female
6.031200E-01
Male-vs-Female
6.328400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.022000E-01
Normal-vs-Age(41-60Yrs)
4.173800E-01
Normal-vs-Age(61-80Yrs)
7.788200E-01
Normal-vs-Age(81-100Yrs)
4.755800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.039800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.445000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.539000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.982500E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.238100E-04
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.673800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.487200E-01
Normal-vs-Daily Drinker
7.387400E-01
Normal-vs-Weekly Drinker
8.534400E-01
Normal-vs-Occasional Drinker
3.810800E-01
Normal-vs-Social Drinker
7.333400E-01
Non Drinker-vs-Daily Drinker
2.734400E-01
Non Drinker-vs-Weekly Drinker
4.803800E-01
Non Drinker-vs-Occasional Drinker
2.971600E-02
Non Drinker-vs-Social Drinker
3.492800E-01
Daily Drinker-vs-Weekly Drinker
8.436400E-01
Daily Drinker-vs-Occasional Drinker
1.313160E-01
Daily Drinker-vs-Social Drinker
6.961200E-01
Weekly Drinker-vs-Occasional Drinker
1.515950E-01
Weekly Drinker-vs-Social Drinker
6.314600E-01
Occasional Drinker-vs-Social Drinker
4.752000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.599400E-01
Normal-vs-Grade 2
1.574230E-01
Normal-vs-Grade 3
1.975600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.175800E-01
Grade 1-vs-Grade 3
1.266980E-01
Grade 1-vs-Grade 4
3.599400E-01
Grade 2-vs-Grade 3
1.838200E-01
Grade 2-vs-Grade 4
1.574230E-01
Grade 3-vs-Grade 4
1.975600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.200800E-01
Normal-vs-NonDiabetic
6.884000E-01
Diabetic-vs-NonDiabetic
3.772800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.034400E-01
Normal-vs-NoPancreatitis
6.785800E-01
Pancreatitis-vs-NoPancreatitis
1.076200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.650200E-01
Normal-vs-N1
7.210200E-01
N0-vs-N1
3.625400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.782600E-01
Normal-vs-TP53-NonMutant
8.503400E-01
TP53-Mutant-vs-TP53-NonMutant
8.958000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
